Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections

Antiviral Research

Volumn 87, Issue 1, 2010, Pages 16-21

  Wang, Bin ^a   Dwyer, Dominic E ^b,c   Blyth, Christopher C ^b   Soedjono, Maly ^a   Shi, Haijing ^a   Kesson, Alison ^c,d   Ratnamohan, Mala ^b   McPhie, Ken ^b   Cunningham, Anthony L ^a   Saksena, Nitin K ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

275Y; A H1N1 09; Amplification; Immuno suppressed; Influenza; Oseltamivir resistance; Rolling Circle

Indexed keywords

OSELTAMIVIR; ZANAMIVIR;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; IMMUNE DEFICIENCY; INFLUENZA A (H1N1); MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; NONHUMAN; PANDEMIC; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEURAMINIDASE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OSELTAMIVIR; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS; VIROLOGY;

ORTHOMYXOVIRIDAE; SUIDAE;

EID: 77953503944     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.04.002     Document Type: Article

References (22)

1. Besselaar T.G., Naidoo D., Buys A., Gregory V., McAnerney J., Manamela J.M., Blumberg L., Schoub B.D. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg. Infect. Dis. 2008, 14:1809-1810.
2. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., Gubareva L.V., Xu X., Bridges C.B., Uyeki T.M. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 2009, 360:2605-2615.
3. de Jong M.D., Tran T.T., Truong H.K., Vo M.H., Smith G.J., Nguyen V.C., Bach V.C., Phan T.Q., Do Q.H., Guan Y., Peiris J.S., Tran T.H., Farrar J. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 2005, 353:2667-2672.
4. Deyde V.M., Gubareva L.V. Influenza genome analysis using pyrosequencing method: current applications for a moving target. Expert Rev. Mol. Diagn. 2009, 9:493-509.
5. Deyde V.M., Sheu T.G., Trujillo A.A., Okomo-Adhiambo M., Garten R., Klimov A.I., Gubareva L.V. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob. Agents Chemother. 2010, 54:1102-1110.
6. Faruqi A.F., Hosono S., Driscoll M.D., Dean F.B., Alsmadi O., Bandaru R., Kumar G., Grimwade B., Zong Q., Sun Z., Du Y., Kingsmore S., Knott T., Lasken R.S. High-throughput genotyping of single nucleotide polymorphisms with rolling circle amplification. BMC Genomics 2001, 2:4.
7. Gerry N.P., Witowski N.E., Day J., Hammer R.P., Barany G., Barany F. Universal DNA microarray method for multiplex detection of low abundance point mutations. J. Mol. Biol. 1999, 292:251-262.
8. Hayden F.G., Treanor J.J., Fritz R.S., Lobo M., Betts R.F., Miller M., Kinnersley N., Mills R.G., Ward P., Straus S.E. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999, 282:1240-1246.
9. Hurt A.C., Barr I.G., Durrant C.J., Shaw R.P., Sjogren H.M., Hampson A.W. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia. Commun. Dis. Intell. 2003, 27:542-547.
10. Ison M.G., Gubareva L.V., Atmar R.L., Treanor J., Hayden F.G. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J. Infect. Dis. 2006, 193:760-764.
11. Kim C.U., Lew W., Williams M.A., Liu H., Zhang L., Swaminathan S., Bischofberger N., Chen M.S., Mendel D.B., Tai C.Y., Laver W.G., Stevens R.C. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 1997, 119:681-690.
12. Kiso M., Mitamura K., Sakai-Tagawa Y., Shiraishi K., Kawakami C., Kimura K., Hayden F.G., Sugaya N., Kawaoka Y. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004, 364:759-765.
13. Kok J., Blyth C.C., Foo H., Patterson J., Taylor J., McPhie K., Ratnamohan V.M., Iredell J.R., Dwyer D.E. Comparison of a rapid antigen test with nucleic acid testing during co-circulation of pandemic influenza A/H1N1 2009 and seasonal influenza A/H3N2. J. Clin. Microbiol. 2009.
14. Lackenby A., Democratis J., Siqueira M.M., Zambon M.C. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antivir. Ther. 2008, 13:809-820.
15. Le Q.M., Wertheim H.F., Tran N.D., van Doorn H.R., Nguyen T.H., Horby P. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N. Engl. J. Med. 2010, 362:86-87.
16. Lizardi P.M., Huang X., Zhu Z., Bray-Ward P., Thomas D.C., Ward D.C. Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat. Genet. 1998, 19:225-232.
17. McKimm-Breschkin J., Trivedi T., Hampson A., Hay A., Klimov A., Tashiro M., Hayden F., Zambon M. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob. Agents Chemother. 2003, 47:2264-2272.
18. Monto A.S., McKimm-Breschkin J.L., Macken C., Hampson A.W., Hay A., Klimov A., Tashiro M., Webster R.G., Aymard M., Hayden F.G., Zambon M. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob. Agents Chemother. 2006, 50:2395-2402.
19. Nilsson M., Malmgren H., Samiotaki M., Kwiatkowski M., Chowdhary B.P., Landegren U. Padlock probes: circularizing oligonucleotides for localized DNA detection. Science 1994, 265:2085-2088.
20. Sheu T.G., Deyde V.M., Okomo-Adhiambo M., Garten R.J., Xu X., Bright R.A., Butler E.N., Wallis T.R., Klimov A.I., Gubareva L.V. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 2008, 52:3284-3292.
21. Steain M.C., Dwyer D.E., Hurt A.C., Kol C., Saksena N.K., Cunningham A.L., Wang B. Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification. Antiviral Res. 2009, 84:242-248.
22. Wang B., Dwyer D.E., Chew C.B., Kol C., He Z.P., Joshi H., Steain M.C., Cunningham A.L., Saksena N.K. Sensitive detection of the K103N non-nucleoside reverse transcriptase inhibitor resistance mutation in treatment-naive HIV-1 infected individuals by rolling circle amplification. J. Virol. Methods 2009, 161:128-135.